Recro Pharma Net Profit Margin 2014-2020 | REPH

Recro Pharma net profit margin from 2014 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Recro Pharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-09-30 $0.08B $-0.03B -34.67%
2020-06-30 $0.08B $-0.03B -34.57%
2020-03-31 $0.10B $-0.03B -26.04%
2019-12-31 $0.10B $-0.02B -19.19%
2019-09-30 $0.10B $-0.05B -50.51%
2019-06-30 $0.09B $-0.06B -64.13%
2019-03-31 $0.08B $-0.07B -83.13%
2018-12-31 $0.08B $-0.08B -101.28%
2018-09-30 $0.08B $-0.06B -78.48%
2018-06-30 $0.08B $-0.06B -74.36%
2018-03-31 $0.07B $-0.05B -73.97%
2017-12-31 $0.07B $-0.05B -69.44%
2017-09-30 $0.07B $-0.04B -51.43%
2017-06-30 $0.07B $-0.03B -45.71%
2017-03-31 $0.07B $-0.03B -44.29%
2016-12-31 $0.07B $-0.03B -43.48%
2016-09-30 $0.07B $-0.01B -13.04%
2016-06-30 $0.07B $-0.01B -8.70%
2016-03-31 $0.07B $0.00B 1.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.055B $0.099B
Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.544B 41.18
Takeda Pharmaceutical (TAK) Japan $57.821B 10.79
Astellas Pharma (ALPMY) Japan $26.791B 16.73
Eisai (ESALY) Japan $22.035B 19.20
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $20.982B 27.52
Catalent (CTLT) United States $15.351B 45.92
Grifols, S.A (GRFS) Spain $12.940B 14.82
Neurocrine Biosciences (NBIX) United States $9.079B 71.45
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.491B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.053B 13.01
IPSEN SA ADR (IPSEY) France $7.714B 0.00
Ionis Pharmaceuticals (IONS) United States $7.174B 70.29
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.650B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $5.834B 12.42
Evotec AG (EVTCY) Germany $5.166B 351.11
PTC Therapeutics (PTCT) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $3.888B 14.30
ChemoCentryx (CCXI) United States $3.863B 0.00
FibroGen (FGEN) United States $3.823B 0.00
Sage Therapeutics (SAGE) United States $3.569B 0.00
Nektar Therapeutics (NKTR) United States $3.099B 0.00
Cronos Group (CRON) Canada $3.042B 0.00
Revolution Medicines (RVMD) United States $2.773B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.693B 13.75
Pacira BioSciences (PCRX) United States $2.661B 57.78
Corcept Therapeutics (CORT) United States $2.657B 25.70
Xencor (XNCR) United States $2.264B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.861B 15.93
Trillium Therapeutics (TRIL) Canada $1.856B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.854B 0.00
Translate Bio (TBIO) United States $1.672B 0.00
USANA Health Sciences (USNA) United States $1.617B 14.23
Heron Therapeutics (HRTX) United States $1.594B 0.00
Ocular Therapeutix (OCUL) United States $1.338B 0.00
Endo (ENDP) Ireland $1.283B 1.95
Karyopharm Therapeutics (KPTI) United States $1.265B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.211B 8.42
Zogenix (ZGNX) United States $1.196B 0.00
Tilray (TLRY) Canada $1.154B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.126B 0.00
Indivior (INVVY) United States $1.099B 13.62
ImmunoGen (IMGN) United States $1.045B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.890B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.845B 0.00
Esperion Therapeutics (ESPR) United States $0.828B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.819B 0.00
VAXART, INC (VXRT) United States $0.797B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.696B 0.00
Radius Health (RDUS) United States $0.691B 0.00
Collegium Pharmaceutical (COLL) United States $0.647B 38.15
Aerie Pharmaceuticals (AERI) United States $0.597B 0.00
Organogenesis Holdings (ORGO) United States $0.569B 0.00
Chinook Therapeutics (KDNY) United States $0.566B 0.00
Flexion Therapeutics (FLXN) United States $0.560B 0.00
Ardelyx (ARDX) United States $0.551B 0.00
Siga Technologies (SIGA) United States $0.541B 15.20
Rigel Pharmaceuticals (RIGL) United States $0.517B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Molecular Templates (MTEM) United States $0.434B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.426B 0.00
Innate Pharma SA (IPHYF) France $0.412B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.399B 0.00
TherapeuticsMD (TXMD) United States $0.399B 0.00
Altimmune (ALT) United States $0.392B 0.00
DURECT (DRRX) United States $0.372B 0.00
Profound Medical (PROF) Canada $0.369B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.366B 9.55
Concert Pharmaceuticals (CNCE) United States $0.342B 0.00
Harpoon Therapeutics (HARP) United States $0.341B 0.00
Rafael Holdings (RFL) United States $0.335B 0.00
KalVista Pharmaceuticals (KALV) United States $0.330B 0.00
Redhill Biopharma (RDHL) Israel $0.330B 0.00
Calithera Biosciences (CALA) United States $0.330B 0.00
MEI Pharma (MEIP) United States $0.323B 0.00
Summit Therapeutics (SMMT) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.301B 0.00
Menlo Therapeutics (VYNE) United States $0.285B 0.00
Lannett Co Inc (LCI) United States $0.276B 7.30
Jounce Therapeutics (JNCE) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.247B 15.94
CTI BioPharma (CTIC) United States $0.243B 0.00
IMV INC (IMV) Canada $0.236B 0.00
Alpine Immune Sciences (ALPN) United States $0.233B 0.00
Otonomy (OTIC) United States $0.227B 0.00
Aquestive Therapeutics (AQST) United States $0.226B 0.00
OptiNose (OPTN) United States $0.223B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Xeris Pharmaceuticals (XERS) United States $0.205B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.199B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.149B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.133B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.133B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.128B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.112B 0.00
ProPhase Labs (PRPH) United States $0.104B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Lipocine (LPCN) United States $0.100B 0.00
India Globalization Capital (IGC) United States $0.092B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.086B 0.00
Sundial Growers (SNDL) Canada $0.086B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.082B 0.00
Biomerica (BMRA) United States $0.080B 0.00
Nutriband (NTRB) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.073B 0.00
Novan (NOVN) United States $0.073B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
Hemispherx BioPharma (AIM) United States $0.072B 0.00
KemPharm (KMPH) United States $0.071B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Natural Alternatives (NAII) United States $0.065B 124.50
CV Sciences (CVSI) United States $0.064B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
GTx (ONCT) United States $0.059B 0.00
Onconova Therapeutics (ONTX) United States $0.058B 0.00
Addex Therapeutics (ADXN) Switzerland $0.058B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 23.08
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.78
Vical (BBI) United States $0.036B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
IsoRay (ISR) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.031B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
PolarityTE (PTE) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 28.19
Hancock Jaffe Laboratories (HJLI) United States $0.017B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Shineco (TYHT) China $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00